Abstract The endosomal sorting complexes required for transport (ESCRT) pathway facilitates multiple fundamental membrane remodeling events. Previously, we determined X-ray crystal structures of ESCRT-III subunit Snf7, the yeast CHMP4 ortholog, in its active and polymeric state (Tang et al., 2015) . However, how ESCRT-III activation is coordinated by the upstream ESCRT components at endosomes remains unclear. Here, we provide a molecular explanation for the functional divergence of structurally similar ESCRT-III subunits. We characterize novel mutations in ESCRT-III Snf7 that trigger activation, and identify a novel role of Bro1, the yeast ALIX ortholog, in Snf7 assembly. We show that upstream ESCRTs regulate Snf7 activation at both its N-terminal core domain and the C-terminus a6 helix through two parallel ubiquitin-dependent pathways: the ESCRT-I-ESCRT-II-Vps20 pathway and the ESCRT-0-Bro1 pathway. We therefore provide an enhanced understanding for the activation of the spatially unique ESCRT-III-mediated membrane remodeling.
Introduction
The endosomal sorting complex required for transport (ESCRT) pathway mediates topologically unique membrane budding events. In multivesicular body (MVB) biogenesis, ESCRT-0, I and II sort ubiquitinated cargo by binding ubiquitin and endosomal lipids. ESCRT-III assembles into spiraling polymers for cargo sequestration, and together with the AAA-ATPase Vps4, remodels the membranes to generate cargo-laden intralumenal vesicles (ILVs).
ESCRT-III is a metastable and conformationally dynamic hetero-polymer of four 'core' subunits, Vps20, Snf7/Vps32, Vps24 and Vps2 (Babst et al., 2002) . All subunits share a common domain organization of an N-terminal helical core domain and a flexible C-terminus, but provide distinct functions. ESCRT-II engages Vps20 to nucleate the polymerization of the most abundant ESCRT-III subunit, Snf7, which then recruits Vps24 and Vps2 (Teis et al., 2008) . Finally, Vps2 engages Vps4 for ESCRT-III disassembly (Obita et al., 2007) .
How is Snf7 activated to promote ESCRT-III assembly and cargo sequestration? Previous studies have shown that ESCRT-II and Vps20 modulate Snf7 protofilaments, emphasizing a role of the upstream ESCRTs in defining the assembly and architecture of the ESCRT-III complex (Henne et al., 2012; Teis et al., 2010) . Recently, we have determined X-ray crystal structures of Snf7 protofilaments in the active conformation (Tang et al., 2015) . Here, using genetics and biochemistry, we identify two parallel ubiquitin-dependent pathways that regulate Snf7 activation through both the Snf7 N-terminal core domain and the C-terminal a6 helix, providing an enhanced understanding of the activation of ESCRT-III-mediated membrane remodeling at endosomes.
Results
The a1/2 hairpin confers Vps20 with a unique identity Although Vps20 and Snf7 display a high degree of homology, they cannot complement each other. In order to identify regions of Vps20 essential for its function, we designed a series of Vps20-Snf7 chimeras and analyzed them by an established quantitative Mup1-pHluorin MVB sorting assay (Henne et al., 2012) . Although a full-length Vps20 is required for function, retaining only the a1/2 hairpin of Vps20 while replacing the remainder of Vps20 with Snf7 (Vps20 1-105 -Snf7 107-240 ) is sufficient for sorting, albeit at~70% efficiency ( Figure 1A , Figure 1 -figure supplements 1-2), suggesting that a1/2 is the minimal region unique to Vps20. This is consistent with the role of a1 of Vps20 in binding to the ESCRT-II subunit Vps25 (Im et al., 2009 ).
Screening for Vps20-independent Snf7 activation mutants
To investigate the role of Vps20 in nucleating Snf7 in vivo, we next applied an unbiased random mutagenic approach. We performed error-prone polymerase chain reaction on SNF7 and selected mutants that suppress the vps20D phenotype by growth on L-canavanine ( Figure 1B) . Two snf7 point mutations in conserved residues, snf7 Q90L and snf7 N100I , showed a partial rescue of the canavanine sensitivity of vps20D ( Figures 1C-1D ). Remarkably, in 'closed' Snf7, Gln90 of a2 is proximal to a4 (Tang et al., 2015) , and Asn100 is an asparagine cap of the a2 helix ( Figure 1E ). We propose that these mutations destabilize closed Snf7 by displacing a4 from a2 and extending the a2/3 helix. Since conformationally active Snf7 resides on membranes, we performed liposome sedimentation assays. As predicted, Q90L enhances Snf7 membrane association from 41% to 78% ( Figure 1F ). To further identify whether these substitutions trigger 'opening' in the core domain, we applied circular dichroism (CD) spectroscopy (Greenfield, 2006; Peter et al., 2004) on Snf7 a1-a4 , a truncated Snf7 construct with reduced membrane binding compared to the full-length proteins (Buchkovich et al., 2013) . In the presence of liposomes, we observed a decrease of the negative absorption band at 208 nm and an increase at 222 nm in Q90L and N100I mutants, indicating an increase of a-helicity ( Figure 1G ). These data agree with the hypothesis that Snf7 Q90L and Snf7 N100I trigger structural rearrangements, where the a2/3 loop becomes a-helical and extends into one elongated a-helix (Figure 1-figure supplement 3) as observed in the open structures (McCullough et al., 2015; Tang et al., 2015) . Notably, this structural rearrangement still occurs only upon membrane binding. Moreover, snf7 Q90L and snf7 N100I complement snf7D in vivo, and Snf7 Q90L assembles into protofilaments in vitro (Figure 1-figure supplement 4) , confirming a functional role of the mutants in activating Snf7.
Auto-activated Snf7 bypasses Vps20
Given that snf7 Q90L and snf7 N100I only modestly suppress vps20D, we hypothesized that a more stabilized 'open' Snf7 on endosomal membranes would improve the suppression. We combined the activation mutations with R52E (Henne et al., 2012) to further trigger 'opening', and swapped a0 of Snf7 with the N-terminal myristoylation motif of Vps20 to enhance its membrane-binding affinity (Buchkovich et al., 2013) . This yielded myr-snf7 R52E Q90L and myr-snf7 R52E Q90L N100I , hereafter denoted as snf7** and snf7***, which sorted cargo with increased efficiencies, albeit not completely restoring wild-type levels ( Figure 2A , Figure 2 -figure supplements 1-2). Consistent with these observations, the ESCRT-dependent cargo GFP-Cps1 partially localized to the vacuolar lumen in vps20D with snf7** or snf7*** ( Figure 2B) , indicating a substantial level of MVB sorting. Moreover, snf7** and snf7*** were also able to rescue the canavanine sensitivity of vps20D ( Figure 2C ). Thus, these snf7 suppressors exhibit the ability to sort cargo at MVB.
To visualize whether the snf7 suppressors could produce ILVs in vivo, we utilized a temperature sensitive allele of the vacuolar SNARE vam7 to accumulate MVBs and examined yeast with thin-section TEM (Buchkovich et al., 2013; Sato et al., 1998) (Figure 2D ). We observed that while ILVs in wild-type cells have a diameter of~32 nm, snf7** and snf7*** show a decrease in ILV number and an increase in ILV diameter to~43 nm ( Figures 2E-F , See Materials and methods). Since ESCRT-II and Vps20 set the architecture of ESCRT-III, we propose that the variation in ILV size is a result of aberrant ESCRT-III architecture, although we cannot completely rule out the possibility of changes in dynamics of ESCRT-III disassembly by Vps4 (Nickerson et al., 2010) . 
Auto-activated Snf7 bypasses ESCRT-I and ESCRT-II
Intrigued by the vps20D suppression, we next wanted to test if these auto-activated Snf7 mutants could also bypass the loss of other ESCRT components ( Figure 3A ). Among them, the downstream ESCRT-III subunits Vps24 and Vps2 are known to modulate Snf7 architecture (Henne et al., 2012; Teis et al., 2008) and recruit the AAA-ATPase Vps4 via their C-terminal MIM motifs for ESCRT-III disassembly (Obita et al., 2007) . We found that auto-activated Snf7 does not suppress vps24D, vps2D or vps4D ( Figure 3B , Figure 3 -figure supplement 1). This is consistent with the role of the suppressors in activating but not modulating or disassembling Snf7 filaments, reinforcing the division of labor among ESCRT-III subunits. Previous studies showed that ESCRT-III assembly is regulated by ESCRT-II (Henne et al., 2012; Teis et al., 2010 ) ( Figure 3A ). ESCRT-II is a Y-shaped heterotetramer of Vps36, Vps22 and two Vps25 (arms). Vps36 GLUE domain binds ubiquitinated cargo and endosome-specific phosphatidylinositol 3-phosphate, PI3P; and each Vps25 'arm' binds one molecule of the ESCRT-III nucleator, Vps20. Since repurposing Snf7 to bind ESCRT-II does not improve the suppression (Figure 3-figure supplement 2), we next tested the functionality of the suppressors in ESCRT-II single and double deletion mutants. Strikingly, snf7** and snf7*** resulted in better suppression in ESCRT-II deletion compared to vps20D, with sorting efficiencies of~60%-70% ( Figure 3C , Figure 3 -figure supplements 3-4).
We next tested ESCRT-I mutants. ESCRT-I is a heterotetramer of Vps23, Vps28, Vps37 and Mvb12. Vps23 UEV domain recognizes ubiquitinated cargo, Vps37 N-terminal helix binds to membranes, and Vps28 CTD engages Vps36 GLUE domain of ESCRT-II. We expressed the suppressors in ESCRT-I single and ESCRT-I/II double deletion mutants and we observed near wild-type sorting efficiencies ( Figure 3D ) with enlarged ILV sizes (Figure 3-figure supplements 5-6). Our data suggest that ESCRT-I and ESCRT-II set up the ESCRT-III architecture to program vesicle dimension.
Auto-activated Snf7 does not bypass Bro1 and ESCRT-0
Because ESCRT-I and ESCRT-II cluster ubiquitinated cargo prior to their packaging into ILVs, the observed suppression indicated that the auto-activated Snf7 might sort cargo in a ubiquitin-independent manner. We next tested whether auto-activated Snf7 could bypass the remaining ubiquitinbinding ESCRT components, ESCRT-0 (Vps27 and Hse1) and, the yeast ALIX ortholog, Bro1/Vps31. Interestingly, the engineered snf7 suppressors do not sort cargo in vps27D or bro1D ( Figures 3E  and G) , or hse1D in combination with vps20D, vps25D (ESCRT-II) or vps23D (ESCRT-I) ( Figure 3F ). To test whether ubiquitin-binding of ESCRT-0 and Bro1 is critical, we expressed ubiquitin-binding mutants vps27 S270D S313D (vps27 UIM ) and bro1 I377R L386R (bro1 UBD ) (Bilodeau et al., 2002; Pashkova et al., 2013) . They reduced the functionality of snf7*** in vps20D, vps25D or vps23D ( Figure 4A , Figure 4 -figure supplement 1). These data suggest that despite the ESCRT-I/II-independence, the suppression is still ubiquitin-dependent (Figure 3-figure supplement 7), perhaps , and myr-snf7 R52E Q90L N100I . Error bars represent standard deviations from 3-5 independent experiments. The data of myr-snf7 (vps20 1-5 -snf7 11-240 ) and SNF7 were re-plotted from Figure 1A for comparsion. Mutants myr-snf7 R52E Q90L and myr-snf7 R52E Q90L N100I are referred to snf7** and snf7***, 
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Quantitative MVB sorting data for (B) vps20D, vps24D, vps2D and vps4D yeast, (C) vps36D, vps22D, vps25D and vps36D vps25D yeast, (D) vps23D, vps28D, vps37D and vps23D vps25D yeast, (E) vps27D, vps27D vps20D, vps27D vps25D and vps27D vps23D yeast, (G) bro1D, bro1D vps20D, bro1D vps25D and bro1D vps23D yeast exogenously expressing VPS20, SNF7, snf7**, and snf7***, respectively. The data from vps20D were partially re-plotted from Figure 2A for comparison. (F) Quantitative MVB sorting data for vps20D hse1D, vps25D hse1D, and vps23D hse1D yeast exogenously expressing VPS20/ VPS25/VPS23 and HSE1, and VPS20/VPS25/VPS23 and empty vector, snf7*** and HSE1, and snf7*** and empty vector, respectively. Error bars represent standard deviations from 3-5 independent experiments. DOI: 10.7554/eLife.15507.010
The following figure supplements are available for figure 3: through another subset of machinery of ESCRT-0 and Bro1. We thus propose that ESCRT-0/Bro1 are required to sort ubiquitinated cargo for ESCRT-III sequestration in parallel to ESCRT-I/II.
Bro1 binds to Snf7 a6 helix and activates Snf7
Bro1 has been shown to directly interact with Snf7, and X-ray crystal structures suggest that the C-terminal a6 helix of Snf7 binds to the Bro1 domain of Bro1 (Kim et al., 2005; McCullough et al., 2008; Wemmer et al., 2011) . To test whether this interaction is required for snf7 suppression, we mutated residues at the Snf7-Bro1 interface. Notably, neither the Bro1-binding defective Snf7*** L231K L234K mutant (snf7*** BRO1 ), nor the Snf7-binding defective Bro1 . This strongly suggests that a6 of Snf7 is also auto-inhibitory, and that a physical binding between Snf7 a6 and Bro1 is a prerequisite for Snf7 activation. We next tested if the Snf7-Bro1 interaction would release the a6 auto-inhibition. While the recombinant Snf7
WT does not assemble due to auto-inhibition, coincubation with Bro1 resulted in Snf7 protofilament assembly ( Figure 4C ), indicating that Bro1 directly triggers Snf7 activation. In agreement with this, the a6 truncated Snf7 (Snf7 1-225 ) releases auto-inhibition and assembles into protofilaments ( Figure 4D ). Therefore, our data suggest that while Snf7 N100I, Q90L, and R52E release auto-inhibition in a3, a4, and a5, respectively, a6 of Snf7 is also auto-inhibitory and its activation is Bro1-dependent ( Figure 4E ).
Discussion
The ancient and conserved ESCRT-III membrane-remodeling machinery plays a critical role in numerous fundamental cellular processes, including MVB biogenesis, viral budding and cytokinesis. Building on our previous study (Tang et al., 2015) , we focused on the predominant ESCRT-III subunit, Snf7, to understand the molecular mechanisms governing ESCRT-III for its dynamic conversion from an auto-inhibited soluble monomer to a membrane-bending polymer. Remarkably, a recent cryo-EM study on ESCRT-III IST1/CHMP1B co-polymer suggested that CHMP1B (Did2/Vps46) undergoes a similar structural rearrangement for assembly (McCullough et al., 2015) , implying that the core domain extension is a common theme of ESCRT-III activation. Here, using a mutagenic approach, we identified novel Snf7 point mutations that release the auto-inhibition of a3 and a4 as observed in the conformationally open structures. Surprisingly, this leads to Snf7 activation that functionally bypasses the ESCRT-III nucleator Vps20, as well as the ESCRT-II and ESCRT-I complexes. This suggests that Snf7, along with its downstream ESCRT components, Vps24, Vps2 and Vps4, but not ESCRT-I/II, are among the minimal machinery required for membrane remodeling.
Our data suggest that ESCRT-III activation is mediated by two parallel pathways, ESCRT-I/II and ESCRT-0/Bro1 ( Figure 4F ). Bro1, directly triggers ESCRT-III assembly by binding to the C-terminal a6 of Snf7 ( Figure 4C ). Given that ESCRT-0 directly engages Bro1 (Lee et al., 2016) to recognize ubiquitinated cargo (Pashkova et al., 2013) , we showed that Snf7 a6 binding to Bro1 relieves vps27D, vps25D vps27D , and vps23D vps27D yeast exogenously expressing VPS20/VPS25/VPS23 and VPS27, snf7*** and VPS27, and snf7*** and vps27 S270D S313D (vps27 UIM ), and vps20D bro1D, vps25D bro1D, and vps23D bro1D yeast exogenously expressing VPS20/VPS25/VPS23 and BRO1, snf7*** and BRO1, and snf7*** and bro1 I377R L386R (bro1 UBD ), respectively, and for (B) vps20D bro1D, vps25D bro1, and vps23D bro1D yeast exogenously expressing snf7*** and BRO1, snf7*** L231K L234K (snf7*** BRO1 ) and BRO1, and snf7***and bro1 I144D L336D (bro1 SNF7 autoinhibiton of Snf7. This adds to the roles for Bro1, besides its recruitment of the Doa4 deubiquitinase in the MVB pathway (Luhtala and Odorizzi, 2004) . Consistent with our observation, a very recent study suggested that ALIX and ESCRT-I/II function as parallel CHMP4B (Snf7 ortholog in human) recruiters in cytokinetic abscission (Christ et al., 2016) .
While biochemical data suggest that Snf7 can be activated by specific point mutations in the core domain or truncation at the C-terminus in vitro, our genetic evidence indicat that the conformational equilibrium of Snf7 is tightly regulated by two pathways in vivo to achieve ubiquitin-dependent cargo sorting at endosomes: 1) ESCRT-I/ESCRT-II/Vps20 activates the N-terminal core domain of Snf7; 2) ESCRT-0/Bro1 activates the C-terminal a6 of Snf7 ( Figures 4E-F) . Our results provide novel insights into a two-stage activation pathway for ESCRT-III-mediated membrane remodeling.
Materials and methods
Fluorescence microscopy, canavanine plating assay, western blotting, protein purification and liposome sedimentation Fluorescence microscopy, western blotting and recombinant Snf7 purification for CD, TEM and liposome sedimentation analysis were performed as described (Buchkovich et al., 2013; Henne et al., 2012; Tang et al., 2015) , and canavanine plating assay as described (Lin et al., 2008) .
For Bro1 purification, Saccharomyces cerevisiae BRO1 was cloned into the pET23d vector (Novagen, Billerica, MA, USA) with an N-terminal His 6 -tag, induced by 1 mM IPTG at 18 o C overnight from BL21 E. coli cells, and purified by TALON metal affinity resin (Clontech). Protein-bound TALON resins were washed in 500 mM NaCl, 20 mM HEPES pH 7.4, 20 mM imidazole, and eluted in 150 mM NaCl, 20 mM HEPES pH 7.4, 400 mM imidazole.
Flow cytometry
The quantitative Mup1-pHluorin ESCRT cargo-sorting flow cytometry assay was performed as described (Buchkovich et al., 2013; Henne et al., 2012; Tang et al., 2015) . Briefly, mid-log yeast cell cultures grown with the addition of 20 mg/mL L-methionine for 2 hr were resuspended in 1x PBS buffer. Mean green fluorescence (FL1-A channel) of 100,000 events was recorded and gated on a BD Accuri C6 flow cytometer. For single ESCRT mutants, take Figure 1A for example: NBY42 (vps20D MUP1-PH) yeast cells were transformed with 1) pRS416 empty vector, 2) pRS416 VPS20, or 3) different mutants, respectively. Gated mean FL1-A values, F, of each sample are recorded and sorting scores are calculated as:
Sorting scores of 3 to 5 independent experiments are used to calculate standard deviation. For double ESCRT mutants, take Figure 3D panel vps23Dvps25D for example. STY64 (vps23D vps25D MUP1-PH) yeast cells were co-transformed with 1) pRS415 empty vector and pRS416 empty vector, 2) pRS415 VPS25 and pRS416 VPS23, 3) pRS415 empty vector and pRS416 VPS20, 4) pRS415 empty vector and pRS416 SNF7, 5) pRS415 empty vector and pRS416 snf7**, or 6) pRS415 empty vector and pRS416 snf7***, respectively. MVB sorting scores are calculated as: Sorting scores of 3 to 5 independent experiments are used to calculate standard deviation.
Yeast strain and plasmids
See Supplementary file 1 for a list of plasmids and yeast strains used in this study.
SNF7 random mutagenesis for vps20D suppressor screening
The DNA sequence of Saccharomyces cerevisiae SNF7 with 500bp of 5'UTR and 500bp of 3'UTR was amplified by Taq DNA polymerase with 20 mM MnCl 2 and manipulated dNTP (N=A, T, G, or C) concentrations of 250 mM for three dNTPs and 25 mM for the other dNTP. Four individual 50 mL PCR reactions with different dNTP ratios were mixed, purified and transformed in vps20D yeast, along with a restriction enzyme digested vector of 3'UTR-pRS416-5'UTR. Yeast cells were plated and grown on YNB-uracil for 3 days at 26 o C, and replica plated on YNB-uracil with 4.0 mg/mL of L-canavanine. Canavanine-resistant yeast colonies were selected, and gap-repaired pRS416 snf7 mutant were prepped, amplified and sequenced.
Circular dichroism spectroscopy
CD experiments were carried out using an Aviv Biomedical CD spectrometer Model 202-01. 10 mM Snf7 core mutants were buffer exchanged by Superdex-200 gel filtration (GE Healthcare Life Sciences)
to 10 mM sodium phosphate buffer pH 7.5. For solution samples, Snf7 core was mixed with an equal volume of buffer. For liposome samples, Snf7 core was mixed with an equal volume of 1.0 mg/mL liposomes of 800 nm diameter, with 60% 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 30% 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (DOPS), 10% phosphatidylinositol 3-phosphate (PI(3)P). The preparation of liposomes was performed as previously described (Henne et al., 2012) . Negative stain transmission electron microscopy Visualization of ESCRT-III assembly using purified recombinant ESCRT components was performed as previously described (Henne et al., 2012) . Visualization of MVB in vam7 tsf yeast cells was performed as previously described (Buchkovich et al., 2013) . Briefly, 30 ODV of mid-log vam7 tsf yeast cells were grown at 38 o C for 3 hr, and then fixed with 2.5% (v/v) glutaraldehyde for 1 hr and spheroplasted with zymolyase and gluculase before embedding in 2% ultra-low temperature agarose. Cells were incubated in 1% osmium tetroxide/1% potassium ferrocyanide for 30 min, 1% thiocarbohydrazide for 5 min, and 1% osmium tetroxide/1% postassium ferrocyanide for 5 min. After dehydration through an ethanol series, samples were transitioned into 100% propylene oxide and embedded in Spurr's resin. Note that osmotic gradients during fixation or dehydration might account for the MVB morphological defects and the larger mean ILV diameter compared to samples prepared by high-pressure freezing and automated freeze-substitution. However, all yeast cells used in these experiments were treated equally. All TEM was performed on a Morgnani 268 transmission electron microscope (FEI) with an AMT digital camera.
